Viking Therapeutics, Inc. (VKTX)’in fiyatı nedir?

Viking Therapeutics, Inc. (VKTX)’in fiyatı $34.49’dir

Viking Therapeutics, Inc. (VKTX)’in piyasa değeri nedir?

Viking Therapeutics, Inc. (VKTX)’in piyasa değeri $4.02B’dir.

Viking Therapeutics, Inc. (VKTX) Temettü Verimi

Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.

Yıl	Temettü Verimi	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Temettü Verimi

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Temettü Verimi	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
CSL Limited CSL.AX	3.12%	AU
Moderna, Inc. MRNA.US	0.00%	US
Lonza Group AG LONN.SW	0.00%	CH

Şirket

Temettü Verimi

Ülke